The organ effects of systemic inflammation response activated during open heart surgery and current treatment methods

References (1)

1. İriz E. Açık kalp cerrahisi esnasında aktive olan sistemik inflamasyon cevabının organ fonksiyonlarına etkileri ve güncel tedavi yöntemleri. Anadolu Kardiyol Derg 2004; 3: 231-5. 2. Di Salvo C, Louca LL, Pattichis K, Hooper J, Walesby RK. Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage. J Cardiovasc Surg (Torino) 1996; 37 (Suppl 1): 93-100. 3. Mihlhaljevic T, Tönz M, von Segesser LK, et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: a clinical study. J Thorac Cardiovasc Surg 1995; 109: 1138-45. 4. Rowe PM. Glimmers of clinical relevance for Fas. Lancet 1996;347: 1398. 5. Scholz M, Simon A, Berg M, et al. In vivo inhibition of neutrophil activity by a FAS (CD95) stimulating module: arterial in-line application in a porcine cardiac surgery model. J Thorac Cardiovasc Surg 2004; 127: 1735-42. 6. Moreno JB, Margraf S, Schuller AM, Simon A, Moritz A, Scholz M. Inhibition of neutrophil activity in cardiac surgery with cardiopulmonary bypass: a novel strategy with the leukocyte inhibition module. Perfusion 2004; 19: 11-6.